Evidence map›Paper›PMID 37368623›Full record

ArticleToxics2023

Disruptive Technologies for Learning and Further Investigation of the Potential Toxicity Produced by Titanium in the Human Body during the COVID-19 Pandemic Period.

Mădălin Dorel Țap, Cristina Stanciu Neculau, George Popescu, Octavia-Sorina Honțaru

Open access · goldAbstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Mădălin Dorel ȚapFaculty of Dental Medicine, "Titu Maiorescu" University of Bucharest, 031593 Bucharest, Romania.
Cristina Stanciu NeculauDepartment of Marketing and Medical Technology, University of Medicine and Pharmacy "Carol Davila" Bucharest, 020021 Bucharest, Romania.
George PopescuEmergency Clinical Hospital Dr. Bagdasar-Arseni, Șoseaua Berceni 12, 041915 Bucharest, Romania.
Octavia-Sorina HonțaruFaculty of Sciences, Physical Education and Informatics, University of Pitesti, Târgul din Vale 1, 110040 Arges, Romania.
Carol Davila University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · ROUniversity of Bucharest · ROUniversity of Pitesti · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Titanium is considered to be a biocompatible material and is used to a great extent in the pharmaceutical and oral implantology fields. While initially, specialists considered that its use does not cause adverse effects on the human body, as time has gone by, it has become clear that its use can lead to the development of certain diseases. The objective of this study was to identify the way in which digital technologies have the capacity to facilitate information regarding the potential long-term harm caused by titanium device toxicity during the COVID-19 pandemic. In this study, a regression model was developed to identify how a series of independent variables have the ability to influence the dependent variable (respondents' perceptions of how new web technologies have the ability to help future physicians to facilitate information absorption with regard to potential titanium toxicity). The results illustrated that new technologies have the potential to support both the learning process on this topic and the innovation activity by discovering new solutions that will gradually lead to the reduction of the side effects of titanium used in the pharmaceutical and oral implantology fields.

Indexed as

COVID-19digital healthcaredisruptive technologiesoral implantologypharmaceutical fieldtitanium toxicity

Identifiers

PMID37368623
PMCPMC10305369
OpenAlexW4380366312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.